Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)

NCT02762188 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.

NCT NCT02762188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02762188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)
Lead sponsor
Brugmann University Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2013
Completion date
January 18, 2018
Enrollment
501 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration